CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling

Abstract

Metastatic relapse remains largely incurable and a major challenge of clinical management in breast cancer, but the underlying mechanisms are poorly understood. Herein, we report that CGI-99 is overexpressed in breast cancer tissues from patients with metastatic recurrence within 5 years. High CGI-99 significantly predicts poorer 5-year metastasis-free patient survival. We find that CGI-99 increases breast cancer stem cell properties, and potentiates efficient tumor lung colonization and outgrowth in vivo. Furthermore, we demonstrate that CGI-99 activates the autocrine interleukin-6 (IL-6)/STAT3 signaling by increasing the accumulation and activity of RNA polymerase II and p300 cofactor at the proximal promoter of IL-6. Importantly, delivery of the IL-6-receptor humanized monoclonal antibody tocilizumab robustly abrogates CGI-99-induced metastasis in vivo. Finally, we find that high levels of CGI-99 are significantly correlated with STAT3 hyperactivation in breast cancer patients. These findings reveal a potential mechanism for constitutive activation of autocrine IL-6/STAT3 signaling and may suggest a novel target for clinical intervention in breast cancer.

TNFα-YAP/p65-HK2 axis mediates breast cancer cell migration

“…Inflammatory cytokines secreted by macrophages, such as TNFα, IL-1 and IL-6, have been reported to take part in tumor cell malignancy. 22 , 23 , 24 These cytokines promote the metastasis of tumor cells via the activation of different signaling pathways. Then, we used the specific inhibitors of these cytokines to define which inflammatory signaling is involved in macrophage-stimulated YAP protein stability and activation.…”

Cancer/testis antigen‐Plac1 promotes invasion and metastasis of breast cancer through Furin/NICD/PTEN signaling pathway

“…Over the past decades, due to the improvement of early detection, as well as the development of more effective adjuvant and targeted therapies, the worldwide mortality of patients with breast cancer significantly decreases. Nevertheless, many patients with breast cancer remain incurable due to relapse and metastasis after surgery and adjuvant therapies (Benckert et al, 2012;Lin et al, 2017). When metastasis occurs, a major step is the functional activation of metastasis-promoting genes, which accelerates a cascade of crucial steps, including the loss of adhesion of the primary tumor cells, invasion through surrounding extracellular matrix, intravasation into the blood and/ or lymphatics with subsequent extravasation from microvasculature of distant organs, colonization, and proliferation at a metastatic site (Valastyan and Weinberg, 2011).…”

Antimetastatic effects of calycosin on osteosarcoma and the underlying mechanism

“…As a downstream component of IκBα, IL‐6 is a cytokine that may be potentially carcinogenic. IL‐6 is playing roles in tumor microenvironment regulation, promoting metastasis by reduction of ECM, and changing tumorous DNA methylation . ECT2 is a transforming protein that is related to Rho‐specific exchange factors for cell cycle and checkpoint .…”

“…IL-6 is playing roles in tumor microenvironment regulation, promoting metastasis by reduction of ECM, and changing tumorous DNA methylation. 35 ECT2 is a transforming protein that is related to Rhospecific exchange factors for cell cycle and checkpoint. 36 In addition, increasing data suggest ECT2 expressions are markedly upregulated in a group of cancer cell lines and tumor samples.…”